Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.13-5.0911.6823.3317.91

What is the latest Core EBITDA Margin ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Margin ratio of LASA SUPERGENERICS is 2.13 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20242.13
Mar2023-5.09
Mar202211.68
Mar202123.33
Mar202017.91

How is Core EBITDA Margin of LASA SUPERGENERICS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.13
Positive
Mar2023 -5.09
Negative
Mar2022 11.68
-49.94
Mar2021 23.33
30.26
Mar2020 17.91 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Margin ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹130.1 Cr 0.7% -10.4% -19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

0.7%

-10.4%

-19.2%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses